Mylan Laboratories Limited
Indian Pharmaceutical Exporter ยท Cardiovascular Specialist ยท $634.8M Total Trade ยท DGFT Verified
Mylan Laboratories Limited is an Indian pharmaceutical exporter with a total trade value of $634.8M across 91 products in 26 therapeutic categories. Based on 13,583 verified export shipments from Indian Customs (DGFT) records, Mylan Laboratories Limited is the #1 Indian exporter in 23 products including Pantoprazole, Valsartan, Trastuzumab. Top exports include Tenofovir ($50.1M), Pantoprazole ($33.0M), Valsartan ($28.9M).
Mylan Laboratories Limited โ Export Portfolio & Destination Treemap

Who is Mylan Laboratories Limited? โ Company Overview & Market Position
Mylan Laboratories Limited, incorporated on November 29, 1984, is a prominent Indian pharmaceutical company specializing in the manufacture of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company is registered under the Corporate Identification Number (CIN) U24231TG1984PLC005146 and is headquartered in Hyderabad, Telangana, India.
As of March 31, 2023, Mylan Laboratories Limited reported an authorized share capital of โน1,250,000,000 and a paid-up capital of โน487,025,270. The company is privately held and operates as a non-government entity. While specific revenue figures are not publicly disclosed, Mylan Laboratories Limited is recognized as a significant player in the Indian pharmaceutical export sector.